| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
79,620,000 |
| Market
Cap: |
12.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1604 - $0.1604 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
178,298 |
343,298 |
| Total Buy Value |
$0 |
$0 |
$1,041,856 |
$1,897,756 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
6 |
12 |
| Total Shares Sold |
1,129,833 |
1,383,088 |
1,419,857 |
2,030,451 |
| Total Sell Value |
$52,883,521 |
$61,477,256 |
$62,474,611 |
$63,437,018 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
23 |
27 |
76 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vivo Ventures Fund V, L.p. |
10% Owner |
– – • |
2017-03-07 |
4 |
B |
$0.00 |
$1,354,043 |
I/I |
1,488,213 |
165,372 |
1.5 |
- |
|
| Vivo Ventures Fund V, L.p. |
10% Owner |
– – • |
2017-03-07 |
4 |
A |
$0.00 |
$0 |
I/I |
5,750,066 |
148,167 |
|
- |
|
| Shah Mahendra |
Director |
– • – |
2017-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
94,584 |
94,584 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2017-01-23 |
4 |
A |
$0.90 |
$15,000 |
D/D |
16,667 |
1,795,929 |
|
- |
|
| Dalal Rajen |
Director |
– • – |
2017-01-23 |
4 |
A |
$0.90 |
$6,584 |
D/D |
7,315 |
7,315 |
|
- |
|
| Engelsen Steinar J |
Director |
– • – |
2017-01-23 |
4 |
A |
$0.90 |
$14,000 |
D/D |
15,556 |
96,516 |
|
- |
|
| Harris William G |
Director |
– • – |
2017-01-23 |
4 |
A |
$0.90 |
$9,405 |
D/D |
10,450 |
20,247 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2016-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
1,779,262 |
|
- |
|
| Harris William G |
Director |
– • – |
2016-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,797 |
9,797 |
|
- |
|
| Anish Bhatnagar |
See Remarks |
• • – |
2016-08-19 |
4 |
B |
$0.96 |
$9,600 |
D/D |
10,000 |
83,419 |
2.81 |
- |
|
| Otoole David D |
See Remarks |
• – – |
2016-08-18 |
4 |
B |
$1.01 |
$2,020 |
D/D |
2,000 |
44,750 |
2.66 |
- |
|
| Mario Ernest |
Director |
– • • |
2016-08-18 |
4 |
B |
$0.99 |
$24,750 |
D/D |
25,000 |
1,763,637 |
3.92 |
- |
|
| Otoole David D |
See Remarks |
• – – |
2016-08-17 |
4 |
B |
$0.92 |
$9,238 |
D/D |
10,000 |
42,750 |
2.74 |
- |
|
| Mario Ernest |
Director |
– • • |
2016-06-08 |
4/A |
B |
$1.24 |
$62,000 |
D/D |
50,000 |
1,738,637 |
3.92 |
- |
|
| Mario Ernest |
Director |
– • • |
2016-06-08 |
4 |
B |
$1.24 |
$62,000 |
D/D |
50,000 |
1,918,637 |
3.92 |
- |
|
| Engelsen Steinar J |
Director |
– • – |
2016-05-23 |
4 |
B |
$1.31 |
$76,242 |
D/D |
58,200 |
80,960 |
2.39 |
- |
|
| Mario Ernest |
Director |
– • • |
2016-05-20 |
4/A |
B |
$1.20 |
$6,764 |
D/D |
5,637 |
1,688,637 |
3.84 |
- |
|
| Mario Ernest |
Director |
– • – |
2016-05-20 |
4 |
B |
$1.20 |
$6,764 |
D/D |
5,637 |
1,868,637 |
2.39 |
- |
|
| Engelsen Steinar J |
Director |
– • – |
2016-05-20 |
4 |
B |
$1.25 |
$11,438 |
D/D |
9,150 |
22,760 |
2.39 |
- |
|
| Mario Ernest |
Director |
– • • |
2016-05-19 |
4/A |
B |
$1.18 |
$50,875 |
D/D |
43,169 |
1,683,000 |
3.92 |
- |
|
| Mario Ernest |
Director |
– • – |
2016-05-19 |
4 |
B |
$1.18 |
$50,875 |
D/D |
43,169 |
1,863,000 |
2.39 |
- |
|
| Engelsen Steinar J |
Director |
– • – |
2016-05-19 |
4 |
B |
$1.21 |
$11,702 |
D/D |
9,671 |
13,610 |
2.39 |
- |
|
| Anish Bhatnagar |
President and CEO |
• • – |
2016-05-13 |
4 |
B |
$1.15 |
$5,745 |
D/D |
5,000 |
73,419 |
2.81 |
- |
|
| Otoole David D |
See Remarks |
• – – |
2016-05-12 |
4 |
B |
$1.16 |
$5,775 |
D/D |
5,000 |
32,750 |
2.74 |
- |
|
| Anish Bhatnagar |
President and CEO |
• • – |
2016-04-08 |
4 |
OE |
$1.20 |
$70,103 |
D/D |
58,419 |
58,419 |
|
- |
|
389 Records found
|
|
Page 14 of 16 |
|
|
